Analysis of (-)-Epigallocatechin-3-Gallate-Induced Apoptosis and Inhibition of Invasiveness in Oral Cavity Carcinoma Squamous Cell Carcinoma According to Expression of c-Met

구강암편평세포암에서 c-Met 발현여부에 따른 (-)-Epigallocatechin-3-Gallate의 세포사멸 및 종양침습억제효과의 변화분석

  • Shin, Yoo-Seob (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Koh, Yoon-Woo (Department of Otolaryngology, Yonsei University College of Medicine) ;
  • Choi, Eun-Chang (Department of Otolaryngology, Yonsei University College of Medicine) ;
  • Kang, Sung-Un (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Hwang, Hye-Sook (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Choo, Oak-Sung (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Lee, Han-Bin (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Kim, Chul-Ho (Department of Otolaryngology, Ajou University School of Medicine)
  • 신유섭 (아주대학교 의과대학 이비인후과학교실) ;
  • 고윤우 (연세대학교 의과대학 이비인후과학교실) ;
  • 최은창 (연세대학교 의과대학 이비인후과학교실) ;
  • 강성운 (아주대학교 의과대학 이비인후과학교실) ;
  • 황혜숙 (아주대학교 의과대학 이비인후과학교실) ;
  • 추옥성 (아주대학교 의과대학 이비인후과학교실) ;
  • 이한빈 (아주대학교 의과대학 이비인후과학교실) ;
  • 김철호 (아주대학교 의과대학 이비인후과학교실)
  • Published : 2011.05.27

Abstract

Hepatocyte growth factor(HGF) and c-Met play an important role in the control of tumor growth and invasion, and they are known to be good prognostic indicators of patient outcome. Epigallocatechin-3-gallate (EGCG) has been shown to have chemopreventive and therapeutic properties by modulating multiple signal pathways regarding the control of proliferation and invasion of cells. In this study, we evaluated the role of c-Met in EGCG-induced inhibition of invasion and apoptosis in an oral cancer cell line. In KB cells where c-Met was knocked down with siRNA, we performed invasion assay and FACS with Annexin V-FITC/PT staining. In addition, we checked the change of mitochondrial membrane potential(MMP) and the generation of reactive oxygen species(ROS). EGCG-induced inhibition of invasiveness was significantly decreased after the knock-down of c-Met. EGCG-induced apoptosis, MMP change and ROS generation was also reduced in c-Met knock-ed-down KB cells. These results suggest that c-Met is involved in EGCG-induced apoptosis and inhibition of invasiveness of oral cancer cell line.

Keywords

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90. https://doi.org/10.3322/caac.20107
  2. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993;90:1937-1941. https://doi.org/10.1073/pnas.90.5.1937
  3. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell. 1991;64:327-336. https://doi.org/10.1016/0092-8674(91)90642-C
  4. Van Roy F, Mareel M. Tumour invasion: Effects of cell adhesion and motility. Trends Cell Biol. 1992;2:163-169. https://doi.org/10.1016/0962-8924(92)90035-L
  5. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol. 2000;183:10-17. https://doi.org/10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I
  6. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984;122:1450-1459. https://doi.org/10.1016/0006-291X(84)91253-1
  7. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W. Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990;111:2097-2108. https://doi.org/10.1083/jcb.111.5.2097
  8. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Van-de Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991;251:802-804. https://doi.org/10.1126/science.1846706
  9. Kim CH, Koh YW, Han JH, Kim JW, Lee JS, Baek SJ, et al. c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma. Head Neck. 2010;32:1655-1664. https://doi.org/10.1002/hed.21383
  10. Kim CH, Moon SK, Bae JH, Lee JH, Han JH, Kim K, et al. Ex-pression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma. Acta Otolaryngol. 2006;126:88-94. https://doi.org/10.1080/00016480510037014
  11. Kim CH, Lee JS, Kang SO, Bae JH, Hong SP, Kahng H. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma. Oral Oncol. 2007;43:1021-1025. https://doi.org/10.1016/j.oraloncology.2006.11.016
  12. Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr. 2003;133:3262S-3267S. https://doi.org/10.1093/jn/133.10.3262S
  13. Crespy V, Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J Nutr. 2004;134:3431S-3440S. https://doi.org/10.1093/jn/134.12.3431S
  14. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 1998;89:254-261. https://doi.org/10.1111/j.1349-7006.1998.tb00556.x
  15. Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 2004;64:8715-8722. https://doi.org/10.1158/0008-5472.CAN-04-2840
  16. Liang YC, Lin-shiau SY, Chen CF, Lin JK. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem. 1997;67:55-65. https://doi.org/10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V
  17. Boros P, Miller CM. Hepatocyte growth factor: A multifunctional cytokine. Lancet. 1995;345:293-295. https://doi.org/10.1016/S0140-6736(95)90279-1
  18. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 1991;67:901-908. https://doi.org/10.1016/0092-8674(91)90363-4
  19. Wang Y, Selden AC, Morgan N, Stamp GW, Hodgson HJ. Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol. 1994;144:675-682.
  20. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun. 1992;182:802-809. https://doi.org/10.1016/0006-291X(92)91803-X
  21. Uchida D, Kawamata H, Omotehara F, Nakashiro K, Kimura-Yanagawa T, Hino S, et al. Role of HGF/c-met system in invasion and me-tastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer. 2001;93:489-496. https://doi.org/10.1002/ijc.1368
  22. Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer. 1998;82:1513-1520. https://doi.org/10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7
  23. Royal I, Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem. 1995;270:27780-27787. https://doi.org/10.1074/jbc.270.46.27780
  24. Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem. 2004;279:12755-12762. https://doi.org/10.1074/jbc.M312333200